Jiaying Zhang

Targeting the SOX2/PARP1 complex to intervene in the growth of esophageal squamous cell carcinoma.

J. Que, Yaxin Yang, M. Jiang, 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

SOX2 inhibits LLGL2 polarity protein in esophageal squamous cell carcinoma via miRNA-142-3p

Yaxin Yang, Kuancan Liu, T. Zhao, 2022, Cancer biology & therapy.

The roles of the SOX2 protein in the development of esophagus and esophageal squamous cell carcinoma, and pharmacological target for therapy.

Kuancan Liu, Shihui Zhang, Yijian Zhou, 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Yamogenin Exhibits Antidepressant-like Effects via Inhibition of ER Stress and Microglial Activation in LPS-Induced Mice.

Li-Tao Yi, Ming Li, Jiaying Zhang, 2023, ACS chemical neuroscience.

HPV16 infection promotes the malignant transformation of the esophagus and progression of esophageal squamous cell carcinoma

Kuancan Liu, Liming Tian, Shihui Zhang, 2023, Journal of medical virology.

Targeting the SOX2/CDP protein complex with a peptide suppresses the malignant progression of esophageal squamous cell carcinoma

Kuancan Liu, T. Zhao, Shihui Zhang, 2023, Cell death discovery.

Agaricus blazei murrill and Enteromorpha prolifera-derived polysaccharides gain therapeutic effects on esophageal squamous cell carcinoma

Kuancan Liu, Penghu Liu, Shihui Zhang, 2024, Journal of Functional Foods.